Edding Genor Group Holdings Ltd

06998

Company Profile

  • Business description

    Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.

  • Contact

    No. 36 Doukou Road
    Room 406, Building 1
    Hengqin New Area
    Guangdong Province
    Zhuhai
    CHN

    https://www.eddingpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,545

Stocks News & Analysis

stocks

ASX share undervalued as margins expected to rebound

This ASX share remains overlooked despite a strong outlook.
stocks

Cheap retail REIT with an attractive yield

Lower consumer spending unlikely to buckle this retail REIT.
stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,185.9070.200.77%
CAC 408,454.887.610.09%
DAX 4024,835.3875.03-0.30%
Dow JONES (US)51,999.67328.640.64%
FTSE 10010,476.2217.99-0.17%
HKSE24,312.16181.79-0.74%
NASDAQ26,376.34307.60-1.15%
Nikkei 22569,902.25497.750.72%
NZX 50 Index13,392.9833.15-0.25%
S&P 5007,511.3542.94-0.57%
S&P/ASX 2008,966.3065.500.74%
SSE Composite Index4,108.0816.180.40%

Market Movers